CVE-2026-44016

CVE-2026-44016 is a high-severity vulnerability in Docling with a CVSS 3.x base score of 8.2. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-94.

Key facts

Description

Docling simplifies document processing by parsing diverse formats and providing integrations with the generative AI ecosystem. FIn versions >= 2.82.0, < 2.91.0, if the HTML backend was explicitly configured for rendering (rendering option by default deactivated), then the Playwright-based rendering feature could allow JavaScript execution and unrestricted network access when processing untrusted HTML documents. An attacker could craft malicious HTML that executes arbitrary JavaScript in the rendering context or makes unauthorized network requests to internal services, potentially leading to SSRF attacks, data exfiltration, or remote code execution in the rendering environment. This vulnerability is fixed in 2.91.0.

Frequently asked questions

What is CVE-2026-44016?
Docling simplifies document processing by parsing diverse formats and providing integrations with the generative AI ecosystem. FIn versions >= 2.82.0, < 2.91.0, if the HTML backend was explicitly configured for rendering (rendering option by default deactivated), then the Playwright-based rendering feature could allow JavaScript execution and unrestricted network access when processing untrusted HTML documents. An attacker could craft malicious HTML that executes arbitrary JavaScript in the rendering context or makes unauthorized network requests to internal services, potentially leading to SSRF attacks, data exfiltration, or remote code execution in the rendering environment. This vulnerability is fixed in 2.91.0.
How severe is CVE-2026-44016?
CVE-2026-44016 has a CVSS 3.x base score of 8.2, rated high severity. It is exploitable over network with high attack complexity, requires no privileges and user interaction. Impact on confidentiality is high, integrity high, and availability low.
Is CVE-2026-44016 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (30th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-44016?
CVE-2026-44016 affects Docling. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2026-44016?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
Does CVE-2026-44016 have an EU (EUVD) identifier?
Yes. CVE-2026-44016 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2026-39003.
When was CVE-2026-44016 published?
CVE-2026-44016 was published on 2026-06-24 and last updated on 2026-06-30.

References

Affected products (1)

More vulnerabilities in Docling

All CVEs affecting Docling →

Other CWE-94 (Code Injection) vulnerabilities

Browse all CWE-94 (Code Injection) vulnerabilities →